The MC4 receptor as a therapeutic target

Drugs of the Future

Volumn 29, Issue 10, 2004, Pages 1065-1074

  Chaki, Shigeyuki ^a   Nakazato, Atsuro ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 [2 (5 BROMO 2 METHOXYPHENYL)ETHYL] 3 FLUOROPHENYL] 4,5 DIHYDRO 1H IMIDAZOLE; G PROTEIN COUPLED RECEPTOR; MCL 0129; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR AGONIST; MELANOCORTIN 4 RECEPTOR ANTAGONIST; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; PEPTIDOMIMETIC DERIVATIVE; PROOPIOMELANOCORTIN; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANXIETY DISORDER; CACHEXIA; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG DEPENDENCE; DRUG INDICATION; DRUG STRUCTURE; DRUG TARGETING; ENERGY; ENZYME ACTIVITY; FEEDING BEHAVIOR; HOMEOSTASIS; HUMAN; NOCICEPTION; NONHUMAN; OBESITY; PAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; STRESS; STRUCTURE ANALYSIS;

EID: 11144248869     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2004.029.10.840349     Document Type: Review

References (91)

1. Gee, C.E., Chen, C.L.C., Roberts, J.L., Thompson, R., Watson, S.J. Identification of proopiomelanocortin neurons in the rat hypothalamus by in situ cDNA-mRNA hybridization. Nature 1983, 306: 374-5.
2. Bagnol, D., Lu, X.Y., Kaelin, C.B. et al. Anatomy of an endogenous antagonist: Relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 1999, 19: R26.
3. Kiss, J.Z., Cassell, M.D., Palkovits, M. Analysis of the ACTH/β-end/α-MSH-immunoreactive afferent input to the hypothalamic paraventricular nucleus of rat. Brain Res 1984, 324: 91-9.
4. Plantinga, L.C., Verhaagen, J., Edwards, P.M., Schrama, L.H., Burbach, J.P., Gispen, W.H. Expression of the pro-opiomelanocortin gene in dorsal root ganglia, spinal cord and sciatic nerve after sciatic nerve crush in the rat. Brain Res Mol Brain Res 1992, 16: 135-42.
5. Van der Kraan, M., Tatro, J.B., Entwistle, M.L., Brakkee, J.H., Burbach, J.P., Adan, R.A., Gispen, W.H. Expression of melanocortin receptors and proopiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins. Brain Res Mol Brain Res 1999, 63: 276-86.
6. Tsou, K., Khachaturian, H., Akil, H., Watson, S.J. Immunocytochemical localization of pro-opiomelanocortin-derived peptides in the adult rat spinal cord. Brain Res 1986, 378: 28-35.
7. Wikberg, J.E.S. Melanocortin receptors: Perspectives for novel drugs. Eur J Pharmacol 1999, 375: 295-310.
8. Lu, D., Willard, D., Patel, I.R. et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptors. Nature 1994, 371: 799-802.
9. Ollmann, M.M., Wilson, B.D., Yang, Y.K. et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278: 135-8.
10. Seechurn, P., Burchill, S.A., Thody, A.J. Effect of α-melanocyte- stimulating hormone on tyrosinase activity in hair follicular and epidermal melanocytes of the mouse. J Endocrinol 1988, 119: 517-22.
11. Voisey, J., van Daal, A. Agouti: From mouse to man, from skin to fat. Pigment Cell Res 2002, 15: 10-8.
12. Broberger, C., Johansen, J., Johansson, C., Schalling, M., Hokfelt, T. The neuropeptide Y/agout/gene-related protein (AGRP) brain circuitry in normal, anorectic and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998, 95: 15043-8.
13. Chhajlani, V., Wikberg, J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992, 309: 417-20.
14. Chhajlani, V., Muceniece, R., Wikberg, J.E. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 1993, 195: 866-73.
15. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Cone, R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257: 1248-51.
16. Gantz, I., Konda, Y., Tashiro, T. et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993, 268: 8246-50.
17. Gantz, I., Miwa, H., Konda, Y. et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993, 268: 15174-9.
18. Haskell-Luevano, C., Monck, E.K. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Peptides 2001, 99: 1-7.
19. Roselli-Rehfuss, L., Mountjoy, K.G., Bobbins, L.S. et al. Identification of a receptor for γ melanocortin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993, 90: 8856-60.
20. Catania, A., Gatti, S., Colombo, G., Lipton, J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004, 56: 1-29.
21. Alvaro, J.D., Tatro, J.B., Quillan, J.M. et al. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol 1996, 50: 583-91.
22. Kishi, T., Aschkenasi, C.J., Lee, C.E., Mountjoy, K.G., Saper, C.B., Elmquist, J.K. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 2003, 457: 213-35.
23. Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B., Cone, R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994, 8: 1298-308.
24. Chhajlani, V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 1996, 38: 73-80.
25. Beltramo, M., Campanella, M., Tarozzo, G. et al. Gene expression profiling of melanocortin system in neuropathic rats supports a role in nociception. Mol Brain Res 2003, 118: 111-8.
26. Sebhat, I.K., Martin, W.J., Ye, Z. et al. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium-3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl) -2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 2002, 45: 4589-93.
27. 4 receptor agonists. Bioorg Med Chem Lett 2003, 13: 3793-6.
28. Richardson, T.I., Ornstein, P.L., Briner, K. et al. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor. J Med Chem 2004, 47: 744-55.
29. 2. Bioorg Med Chem Lett 2003, 13: 2337-40.
30. Xi, N., Hale, C., Kelly, M.G. et al. Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core. Bioorg Med Chem Lett 2004, 14: 377-81.
31. 4 receptor agonists and their effects on feeding behavior in rats. Bioorg Med Chem 2003, 11: 185-92.
32. Arasasingham, P.M., Fotsch, C., Ouyang, X. et al. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: Antagonists for the AGRP/melanocortin receptor binding. J Med Chem 2003, 46: 9-11.
33. Chaki, S., Hirota, S., Funakoshi, T. et al. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4- isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxy-naphthalen-1-yl)butyl]piperazine) , a novel and potent nonpeptide antagonist of the malanocortin-4 receptor. J Pharmacol Exp Ther 2003, 304: 818-26.
34. Vos, T.J., Caracoti, A., Che, J.L. et al. Identification of 2-[2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H- imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model. J Med Chem 2004, 47: 1602-4.
35. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., Cone, R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385: 165-8.
36. Huszar, D., Lynch, C.A., Fairchild-Huntress, V. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88: 131-41.
37. Cepoi, D., Phillips, T., Cismowski, M. et al. Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis. Brain Res 2004, 1000: 64-71.
38. Benoit, S.C., Schwartz, M.W., Lachey, J.L. et al. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J Neurosci 2000, 20: 3442-8.
39. Kask, A., Mutulis, F., Muceniece, R. et al. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo. Endocrinology 1998, 139: 5006-14.
40. 4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol 1998, 360: 15-9.
41. Schwartz, M.W., Seeley, R.J., Woods, S.C. et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997, 46: 2119-23.
42. Seeley, R.J., Yagaloff, K.A., Fisher, S.L. et al. Melanocortin receptors in leptin effects. Nature 1997, 390: 349.
43. Williams, D.L., Bowers, R.R., Bartness, T.J., Kaplan, J.M., Grill, H.J. Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology 2003, 144: 4692-7.
44. Jonsson, L., Skarphedinsson, J.O., Skuladottir, G.V. et al. Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport 2001, 12: 3703-8.
45. Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., Froguel, P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000, 106: 253-62.
46. Branson, R., Potoczna, N., Kral, J.G., Lentes, K.U., Hoehe, M.R., Horber, F.F. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. New Engl J Med 2003, 348: 1096-103.
47. Tao, Y.X., Segaloff, D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 2003, 144: 4544-51.
48. 4 receptor blockade reduces immobilization stress-induced anorexia in rats. Eur J Pharmacol 1999, 369: 11-5.
49. 4 receptor in stress-related behavior in rodents. Eur J Pharmacol 2003, 474: 95-101.
50. Vink, T., Hinney, A., van Elburg, A.A. et al. Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol Psychiatry 2001, 6: 325-8.
51. Tisdale, M.J. Cancer anorexia and cachexia. Nutrition 2001, 17:438-42.
52. Inui, A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 1999, 59: 4493-501.
53. Plata-Salaman, C., Ilyin, S.E., Gayle, D. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol 1998, 275: R566-73.
54. Wisse, B.E., Frayo, S., Schwartz, M.W., Cummings, D.E. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001, 142: 3292-301.
55. Marks, D.L., Ling, N., Cone, R.D. Role of the central melanocortin system in cachexia. Cancer Res 2001, 61: 1432-8.
56. Marks, D.L., Butler, A.A., Turner, R., Brookhart, G.., Cone, R.D. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 2003, 144: 1513-23.
57. Bednarek, M.A., MacNeil, T., Kalyani, R.N., Tang, R., Van der Ploeg, L.H., Weinberg, D.H. Selective, high affinity peptide antagonists of α-melanotropin action at human melanocortin receptor 4: Their synthesis and biological evaluation in vitro. J Med Chem 2001, 44: 3665-72.
58. Joppa, M.A., Markinson, S., Gogas, K.R., Ling, N., Foster, A.C. Evidence of a role for central mc4 receptors in the anorexia induced by IL-1β. 33rd Annu Meet Soc Neurosci (Nov 8-12, New Orleans) 2003, Abst 398.11
59. Argiolas, A., Melis, M.R., Murgia, S., Schioth, H.B. ACTH-and α-MSH-induced grooming, stretching, yawning and penile erection in male rats: Site of action in the brain and role of melanocortin receptors. Brain Res Bull 2000, 51: 425-34.
60. Van der Ploeg, L.H.T., Martin, W.J., Howard, A.D. et al. A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 2002, 99: 11381-6.
61. Wessells, H., Fuciarelli, K., Hansen, J. et al. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction. J Urol 1998, 160: 389-93.
62. Wessells, H., Gralnek, D., Dorr, D., Hruby, V.J., Hadley, M.E., Levine, N. Effect of an α-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urologia 2000, 56: 641-6.
63. Holmes, A., Heilig, M., Rupniak, N.M.J., Steckler, T., Griebel, G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 2003, 24: 580-8.
64. Adan, R.A.H., Szklarczyk, A.W., Oosterom, J. et al. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat. Eur J Pharmacol 1999, 378: 249-58.
65. Von Frijtag, J.C., Croiset, G., Gispen, W.H., Adan, R.A.H., Wiegant, V.M. The role of central melanocortin receptors in the activation of the hypothalamus-pituitary-adrenal-axis and the induction of excessive grooming. Br J Pharmacol 1998, 123: 1503-8.
66. Dhillo, W.S., Small, C.J., Seal, L.J., Kim, M.S., Stanley, S.A., Murphy, K.G., Ghatei, M.A., Bloom, S.R. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinol 2002, 75: 209-16.
67. Aguilera, G., Rabadan-Diehl, C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: Implications for stress adaptation. Regul Peptides 2000, 96: 23-9.
68. Bloom, F.E., Battenberg, E.L., Rivier, J., Vale, W. Corticotropin releasing factor (CRF): Immunoreactive neurons and fibers in rat hypothalamus. Regul Pept 1982, 4: 43-8.
69. Hwang, B.H., Guntz, J.M. Downregulation of corticotropin-releasing factor mRNA, but not vasopressin mRNA, in the paraventricular hypothalamic nucleus of rats following nutritional stress. Brain Res Bull 1997, 43: 509-14.
70. Liposites, Z., Sievers, L., Paull, W.K. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry 1988, 88: 227-34.
71. Mihaly, E., Fekete, C., Lechan, R.M., Liposits, Z. Corticotropin- releasing hormone-synthesizing neurons of the human hypothalamus receive neuropeptide Y-immunoreactive innervation from neurons residing primarily outside the infundibular nucleus. J Comp Neurol 2002, 446: 235-43.
72. Baubet, V., Fevre-Montange, M., Gay, N., Debilly, G., Bobillier, P., Cespuglio, R. Effects of an acute immobilization stress upon proopiomelanocortin (POMC) mRNA levels in the mediobasal hypothalamus: A quantitative in situ hybridization study. Brain Res Mol Brain Res 1994, 26: 163-8.
73. Larsen, P.J., Mau, S.E. Effect of acute stress on the expression of hypothalamic messenger ribonucleic acids encoding the endogenous opioid precursors preproenkephalin A and proopiomelanocortin. Peptides 1994, 15: 783-90.
74. Yamano, Y., Yoshioka, M., Toda, Y. et al. Regulation of CRF, POMC and MC4R gene expression by electrical foot shock stress in rat amygdala and hypothalamus. J Vet Med Sci, In press.
75. Corda, M.G., Orlandi, M., Fratta, W. Proconflict effect of ACTH 1-24: interaction with benzodiazepines. Pharmacol Biochem Behav 1990, 36: 631-4.
76. Gonzalez, M.I., Vaziri, S., Wilson, C.A. Behavioral effects of α-MSH and MCH after central administration in the female rat. Peptides 1996, 17: 171-7.
77. Panksepp, J., Normansell, L. Effects of ACTH (1-24) and ACTH/MSH (4-10) on isolation-induced distress vocalization in domestic chicks. Peptides 1990, 11: 915-9.
78. File, S.E., Clarke, A. Intraventricular ACTH reduces social interaction in male rats. Pharmacol Biochem Behav 1980, 12: 711-5.
79. Pigott, T.A., Seay, S.M. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1999, 60: 101-6.
80. Takamori, K., Yoshida, S., Okuyama, S. Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life Sci 2001, 69: 1919-26.
81. 4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade. Brain Res 2003, 990: 113-9.
82. Cabeza de Vaca, S., Kim, G.Y., Carr, K.D. The melanocortin receptor agonist MT II augments the rewarding effect of amphetamine in ad-libitum-fed and food-restricted rats. Psychopharmacology 2002, 161: 77-85.
83. Alvaro, J.D., Taylor, J.R., Duman, R.S. Molecular and behavioral interactions between central melanocortins and cocaine. J Pharmacol Exp Ther 2003, 304: 391-9.
84. 4-R) mediates the rewarding effects of cocaine. 31st Annu Meet Soc Neurosci (Nov 10-15, San Diego) 2001, Abst 440.6
85. 4 receptor mediates α-MSH induced release of nucleus accumbens dopamine. Neuroreport 2001, 12: 2155-8.
86. Arner, S., Meyerson, B.A. Lack of analgesic effects of opioids on neuropathic and idiopathic forms of pain. Pain 1988, 33: 11-23.
87. Max, M.B., Schafer, S.C., Culnane, M., Dubner, R., Gracely, R.H. Association of pain relief with drug side-effects in postherpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen and placebo. Clin Pharmacol Ther 1988, 43: 363-71.
88. Bertolini, A., Poggioli, R., Ferrari, F. ACTH-induced hyperalgesia in rats. Experientia 1979, 35: 1216-7.
89. Sandman, C.A., Kastin, A.J. Intraventricular administration of MSH induces hyperalgesia in rats. Peptides 1981, 2: 231-3.
90. Vrinten, D.H., Gispen, W.H., Groen, G.J., Adan, R.A.H. Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats. J Neurosci 2000, 20: 8131-7.
91. Vrinten, D.H., Adan, R.A.H., Groen, G.J., Gispen, W.H. Chronic blockade of melanocortin receptors alleviates allodynia in rats with neuropathic pain. Anesth Analg 2001, 93: 1572-7.